Opportunity
Simpler Grants.gov #RFA-EB-28-004
NIH NextTech grants for translational development of diagnostic and therapeutic devices
Buyer
National Institutes of Health
Posted
October 23, 2026
Respond By
December 01, 2030
Identifier
RFA-EB-28-004
NAICS
541715, 541714, 541713
The National Institutes of Health is supporting translational development of next-generation devices through its NextTech grant opportunity. - Government buyer: National Institutes of Health (NIH); supports the BRAIN and HEAL Initiatives. - Opportunity: RFA-EB-28-004, a grant program for developing technologies to prevent, monitor, diagnose, or treat conditions within the initiatives’ missions. - Funding: $6,000,000 in total program funding; NIH expects to make four awards. Individual award amounts are not specified. - Requested work: Develop and optimize technologies and conduct studies that prepare devices for approvals for human use, with the goal of advancing them toward first-in-human trial readiness. - Important requirement: Clinical trials are not allowed under this opportunity. - OEMs and vendors: None identified. No specific products, part numbers, or purchase quantities are requested.
Description
This funding opportunity invites investigators to advance next-generation technologies for preventing, monitoring, diagnosing, and treating disorders within the missions of the NIH BRAIN and HEAL Initiatives. Funded activities will advance devices toward readiness for first-in-human clinical trials by addressing challenges identified in preliminary proof-of-concept studies. The scope includes technology development and optimization, as well as studies to prepare for approvals for human use. The source lists total program funding of $6,000,000 and expects four awards; award minimum and maximum amounts are not specified.